Sponsor study identifier
observational
37
1 country
1
Study Start
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2009
Actual (reported)Study Completion
April 2009
Actual (reported)The purpose of the study is to prospectively measure pain, function, and patient satisfaction in 70 consecutive patients treated by lumbar fusion using the Triad allograft. Results of the Triad allograft will be compared to those of other anterior lumbar interbody fusion (ALIF), transforaminal lumbar interbody fusion (TLIF), and posterior lumbar interbody fusion (PLIF) surgeries. Patient participation is based on the physician determination that the patient requires one of these surgeries. Participants will be evaluated pre-operatively and post-operatively at 3, 6, 12,and 24 month intervals. Clinic procedures will be related to standard of care except for the completion of several study questionnaires:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2009
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
September 13, 2005
Actual (reported)September 20, 2005
Actual (reported)April 2009
Actual (reported)April 2009
Actual (reported)Triad allograft
other anterior lumbar interbody fusion (ALIF)
transforaminal lumbar interbody fusion (TLIF)
posterior lumbar interbody fusion (PLIF)
70 consecutive patients treated by lumbar fusion using the Triad allograft
UW Health Spine Clinic
Madison, Wisconsin, 53705, United States
Paul Anderson, MD
University of Wisconsin, Madison
37 participants (actual enrollment reported by the registry).
First Submitted
September 13, 2005
First Posted
September 20, 2005
Study Start
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.
Contact the study team to confirm eligibility.
Primary Completion
April 2009
Actual (reported)Study Completion
April 2009
Actual (reported)Last Updated
March 13, 2019
Record last verified: 2019-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: